Rebecca Kahn

2.8k citations
45 papers · 978 indexed · h-index 18
Topics
COVID-19 epidemiological studies (26 papers)SARS-CoV-2 and COVID-19 Research (17 papers)Vaccine Coverage and Hesitancy (11 papers)

In The Last Decade

Rebecca Kahn

43 papers receiving 952 citations

Peers

Rebecca Kahn
Comparison fields: 5 of 101
  • Infectious Diseases 523
  • Modeling and Simulation 498
  • Epidemiology 204
  • Health 200
  • Economics and Econometrics 93
Replace Dan Yamin with:
Dan Yamin Israel
Valentina Marziano Italy
Kevin van Zandvoort United Kingdom
Kiesha Prem United Kingdom
Olivier le Polain de Waroux United Kingdom
Anne M. Presanis United Kingdom
Marta Colaneri Italy
Patrick T. Wedlock United States
Juliette Paireau France
Theresa Tam Canada
Rebecca Kahn relative to Dan Yamin Israel Dan Yamin's profile →
Citations per field
00.5×1.5×2.2×
Dan Yamin · 1×
Citations per year

Countries citing papers authored by Rebecca Kahn

Since Specialization
Citations

This map shows the geographic impact of Rebecca Kahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rebecca Kahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rebecca Kahn more than expected).

Fields of papers citing papers by Rebecca Kahn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rebecca Kahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rebecca Kahn. The network helps show where Rebecca Kahn may publish in the future.

Co-authorship network of co-authors of Rebecca Kahn

This figure shows the co-authorship network connecting the top 25 collaborators of Rebecca Kahn. A scholar is included among the top collaborators of Rebecca Kahn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rebecca Kahn. Rebecca Kahn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 1
3 5
4 43
5 10
6 0
7 6
8 30
9 3
10 23
11 44
12 51
13 41
14 11
15 73
16 10
17 21
18 60
19 2
20 5

About Rebecca Kahn

Rebecca Kahn is a scholar working on Modeling and Simulation, Health and Infectious Diseases, having authored 45 papers that have together received 978 indexed citations. Recurring topics across this work include COVID-19 epidemiological studies (26 papers), SARS-CoV-2 and COVID-19 Research (17 papers) and Vaccine Coverage and Hesitancy (11 papers). The work is most often cited by research in Modeling and Simulation (498 citations), Infectious Diseases (523 citations) and Health (200 citations). Rebecca Kahn has collaborated with scholars based in United States, Sierra Leone and Switzerland. Frequent co-authors include Marc Lipsitch, Caroline O. Buckee, Ruoran Li, Michael J. Mina, Yonatan H. Grad, Corey M. Peak, Lauren M. Childs, Inga Holmdahl, Lee Kennedy‐Shaffer and Jennifer R. Verani. Their work appears in journals such as Cell, Proceedings of the National Academy of Sciences and Nature Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026